Prognosis
Moderna Eyes Testing Mpox, Bird Flu Vaccines in Humans This Year
- Questions remain about how far company would take development
- Company also looking at making two Covid boosters this fall
Vials of the Moderna Inc. Covid-19 vaccine.
Photographer: Veejay Villafranca/BloombergThis article is for subscribers only.
Moderna Inc. is eyeing possible human testing of shots to fight mpox and bird flu this year, as the Covid-19 vaccine maker expands into more public-health immunizations.
The company is exploring messenger RNA vaccines for a number of such pathogens, most of them in the early stages of development, President Stephen Hoge said Monday in an interview. Moderna expects to advance its vaccines for mpox and bird flu to clinical trials after completing initial work on them, he said.